These findings suggested that sestrin2 plays a major role in regulating monocyte activation via the AMPK-mTOR signaling pathway under diabetic and dyslipidemic conditions and that sestrin2 has a protective role against atherosclerosis. This evidence concerns the gene MTOR and atherosclerosis.